(NasdaqGM:XENE), VANCOUVER, British Columbia and BOSTON, Nov. 06, 2025 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development and commercialization of life-changing therapeutics for patients in need, today announced that the Company will present at two upcoming investor conferences. Stifel 2025 Healthcare ConferenceThursday, November 13, 2025 […]

(NasdaqGM:KOID), NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — KraneShares, a leading provider of exchange-traded funds (ETFs) delivering access to emerging technologies and innovative global asset classes, today announced that the KraneShares Global Humanoid and Embodied Intelligence Index ETF (Ticker: KOID) has been approved on Stifel's investment platform, expanding availability to the firm's extensive network

(NASDAQ:RWAY), MENLO PARK, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Runway Growth Finance Corp. (Nasdaq: RWAY) (“Runway Growth” or the “Company”), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that its Board of Directors has declared a fourth quarter 2025 cash distribution of

(NasdaqGM:IRON), Submitted a New Drug Application (NDA) for accelerated approval of bitopertin in erythropoietic protoporphyria (EPP) on September 29, 2025; Awarded the FDA Commissioner's National Priority Voucher (CNPV), which is designed to shorten the expected NDA review period to 1-2 months from NDA acceptance Acceleration of ongoing efforts to support the potential earlier approval and

(NASDAQ:ALGS), SOUTH SAN FRANCISCO, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biotechnology company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today reported recent business progress and financial results for the third quarter 2025. “Our Phase 2 B-SUPREME study of pevifoscorvir

(NYSE:BBWI), COLUMBUS, Ohio, Nov. 06, 2025 (GLOBE NEWSWIRE) — Bath & Body Works, Inc. (NYSE: BBWI) announced today that it plans to report its third quarter 2025 financial results before market open on Thursday, November 20, 2025. In conjunction with this report, the company will host a conference call at 8:30 a.m. ET during which

(NASDAQ:ZSPC), SAN JOSE, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) — zSpace, Inc. (NASDAQ: ZSPC), a global leader in immersive augmented (AR) solutions for education, today announced the international availability of the zSpace Inspire 2 Laptop at the GESS Dubai 2025 Conference, taking place November 11-13 at the Dubai World Trade Centre. The company will highlight

(NASDAQ:THFF), TERRE HAUTE, Ind. and LEBANON, Tenn., Nov. 06, 2025 (GLOBE NEWSWIRE) — First Financial Corporation (NASDAQ: THFF) (“First Financial”) and CedarStone Financial, Inc. (“CedarStone”) jointly announced today the execution of a definitive agreement under which First Financial will acquire CedarStone. First Financial will pay $19.12 per share in cash for each share of CedarStone's

(NASDAQ:QNRX), – Private Placement Financing of Up to $105.3 Million Closed in October 2025 to Fund Operations and R&D – Sally Lawlor Appointed CFO to Support Commercialization and Financial Operations – Orphan Drug Designation Awarded by FDA to QRX003 for Netherton Syndrome – Pediatric Netherton Clinical Program Expanded Based on Positive Long-Term Safety and Efficacy

(NASDAQ:PYPD), PETACH TIKVA, Israel, Nov. 06, 2025 (GLOBE NEWSWIRE) — PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company focused on improving surgical outcomes, today announced that D-PLEXâ‚₀₀, the company's lead candidate, has been named “Therapeutics Solution of the Year” by BioTech Breakthrough, a leading independent market intelligence organization which evaluates and